Role of Endothelium in Doxorubicin-Induced Cardiomyopathy
JACC: Basic to Translational Science(2018)
摘要
The clinical use of doxorubicin in cancer is limited by cardiotoxic effects that can lead to heart failure. Whereas earlier work focused on the direct impact of doxorubicin on cardiomyocytes, recent studies have turned to the endothelium, because doxorubicin-damaged endothelial cells can trigger the development and progression of cardiomyopathy by decreasing the release and activity of key endothelial factors and inducing endothelial cell death. Thus, the endothelium represents a novel target for improving the detection, management, and prevention of doxorubicin-induced cardiomyopathy.
更多查看译文
关键词
cardiomyopathy,doxorubicin,endothelium,heart failure
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络